NCT00551005View on ClinicalTrials.gov

Etoposide and Celecoxib in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

celecoxib

DRUG

etoposide

OTHER

immunoenzyme technique

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00551005 - Etoposide and Celecoxib in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter